Table 10.
No. | Fragrant Compounds | Route of Administration | Dose | Duration | Model | Effects on Appetite | Mechanism | References |
---|---|---|---|---|---|---|---|---|
1 | Benzylacetone | Inhalation | 4.5 × 10−4 mg/cage | 1 h | ddY mice | Increase | Increase NPY mRNA expression | [54] |
Intraperitoneal injection | 0.01–1 μg/kg | 1 h | ddY mice | No effect | n/a | [54] | ||
Inhalation | 7.4 × 10−8–7.4 × 10−2 mg/cm3 | 5–60 min | ddY mice | Increase | n/a | [55] | ||
Inhalation | 7.4 × 10−8–7.4 × 10−2 mg/cm3 | 5–60 min | ddY mice | Increase | n/a | [65] | ||
Inhalation | 4.5 × 10−4 mg/cage | 1 h | ddY mice | Increase | n/a | [67] | ||
2 | Eugenol | Inhalation | 4.5 × 10−4 mg/cage | 1 h | ddY mice | Increase | n/a | [53] |
Inhalation | 4.5 × 10−4–2.5 × 10−3 mg/cage | 1 h | ddY mice | Increase | n/a | [61] | ||
Intraperitoneal injection | 0.01–1 μg/kg | 1 h | ddY mice | No effect | n/a | [61] | ||
Inhalation | 4.5 × 10−4 mg/cage | 1 h | ddY mice | Increase | n/a | [67] | ||
3 | trans-Anethole | Inhalation | 4.5 × 10−4 mg/cage | 1 h | ddY mice | Increase | n/a | [53] |
Oral | 250 mg/kg | 10 weeks | Wistar rats | Decrease | n/a | [63] | ||
Inhalation | 4.5 × 10−4 mg/cage | 1 h | ddY mice | Increase | n/a | [67] | ||
4 | Vanillin | Inhalation | 4.5 × 10−5–4.5 × 10−3 mg/cage | 1 h | ddY mice | Increase | n/a | [61] |
Intraperitoneal injection | 0.01–1 μg/kg | 1 h | ddY mice | No effect | n/a | [61] |
n/a, not applicable; NPY, neuropeptide Y.